Chemotherapy With or Without Bevacizumab or Lapatinib to Treat Operable Oesophagogastric Cancer

PHASE2/PHASE3UnknownINTERVENTIONAL
Enrollment

1,103

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Oesophagogastric Cancer
Interventions
BIOLOGICAL

bevacizumab

7.5mg/kg IV Day 1 of each 21 cycle of chemotherapy (6 cycles) plus day 1 of each maintenance dose every 21 days for 6 doses.

DRUG

capecitabine

dose banded as based on patient BSA. Oral dose given twice a day during each 21 day cycle of chemotherapy (6 cycles in total)

DRUG

cisplatin

60mg/m2 IV day one of each 21 day cycle of chemotherapy (6 cycles in total)

DRUG

Epirubicin

50mg/m2 IV day one of each 21 day cycle of chemotherapy (6 cycles in total)

PROCEDURE

adjuvant therapy

3 cycles of ECX chemotherapy post operatively

PROCEDURE

conventional surgery

Surgery undertaken after 3 cycles of pre-operative chemotherapy. Followed by 3 cycles of chemotherapy.

PROCEDURE

neoadjuvant therapy

3 cycles of pre-operative ECX chemotherapy.

DRUG

Lapatinib

1250mg/day Day 1-21 of each cycle of chemotherapy (6 cycles) plus day 1-21 of each maintenance course every 21 days for 6 doses.

Trial Locations (41)

BH7 7DW

RECRUITING

Royal Bournemouth Hospital, Bournemouth

BD9 6RJ

ACTIVE_NOT_RECRUITING

Bradford Royal Infirmary, Bradford

BS2 8ED

RECRUITING

Bristol Haematology and Oncology Centre, Bristol

CB2 2QQ

ACTIVE_NOT_RECRUITING

Addenbrooke's Hospital, Cambridge

CA2 7HY

ACTIVE_NOT_RECRUITING

Cumberland Infirmary, Carlisle

DN2 5LT

RECRUITING

Doncaster Royal Infirmary, Doncaster

GU2 7XX

RECRUITING

St. Luke's Cancer Centre at Royal Surrey County Hospital, Guildford

HD3 3EA

RECRUITING

Huddersfield Royal Infirmary, Huddersfield, West Yorks

LS9 7TF

RECRUITING

Leeds Cancer Centre at St. James's University Hospital, Leeds

LN2 5QY

ACTIVE_NOT_RECRUITING

Lincoln County Hospital, Lincoln

L9 7AL

RECRUITING

Aintree University Hospital, Liverpool

EC1A 7BE

RECRUITING

Saint Bartholomew's Hospital, London

SW17 0QT

ACTIVE_NOT_RECRUITING

St. George's Hospital, London

W2 1NY

ACTIVE_NOT_RECRUITING

St. Mary's Hospital, London

ME16 9QQ

RECRUITING

Mid Kent Oncology Centre at Maidstone Hospital, Maidstone

M20 4BX

RECRUITING

Christie Hospital, Manchester

CH63 4JY

RECRUITING

Clatterbridge Centre for Oncology, Merseyside

NE4 6BE

RECRUITING

Northern Centre for Cancer Treatment at Newcastle General Hospital, Newcastle upon Tyne

PL6 8DH

ACTIVE_NOT_RECRUITING

Derriford Hospital, Plymouth

BH15 2JB

ACTIVE_NOT_RECRUITING

Dorset Cancer Centre, Poole Dorset

RG1 5AN

RECRUITING

Berkshire Cancer Centre at Royal Berkshire Hospital, Reading

0L12 0NB

ACTIVE_NOT_RECRUITING

Rochdale Infirmary, Rochdale

SP2 8BJ

RECRUITING

Salisbury District Hospital, Salisbury

SL2 4HL

RECRUITING

Wexham Park Hospital, Slough, Berkshire

SO16 6YD

RECRUITING

Southampton General Hospital, Southampton

SM2 5PT

RECRUITING

Royal Marsden - Surrey, Sutton

AB25 2ZN

RECRUITING

Aberdeen Royal Infirmary, Aberdeen

CF14 2TL

RECRUITING

Velindre Cancer Center at Velindre Hospital, Cardiff

Unknown

RECRUITING

Basingstoke and North Hampshire Hospital, Basingstoke

RECRUITING

Birmingham Heartlands Hospital, Birmingham

RECRUITING

Castle Hill Hospital, Cottingham

RECRUITING

University Hospitals Coventry and Warwickshire, Coventry

RECRUITING

Beatson West of Scotland Cancer Centre, Glasgow

RECRUITING

St James Hospital, Leeds

RECRUITING

Leicester Royal Infirmary, Leicester

RECRUITING

Norfolk and Norwich University Hospital, Norwich

RECRUITING

Churchill Hospital, Oxford

RECRUITING

Queens Hospital, Romford

RECRUITING

Weston Park, Sheffield

RECRUITING

Great Western Hospital, Swindon

RECRUITING

Musgrove Park Hospital, Taunton

Sponsors
All Listed Sponsors
collaborator

Cancer Research UK

OTHER

collaborator

Roche Pharma AG

INDUSTRY

collaborator

GlaxoSmithKline

INDUSTRY

lead

Professor David Cunningham

OTHER_GOV